RevolKa Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $5.72M

  • Investors
  • 7

RevolKa General Information

Description

Developer of an artificial intelligence-driven protein engineering platform designed for biopharmaceutical development. The company's technology uses AI-driven protein technology, directed protein evolution, machine learning integration, low-n learning, bioinformatics, protein language models, generative artificial intelligence, and sequence-function prediction, enabling pharmaceutical companies to create novel proteins for therapeutics and industrial uses.

Contact Information

Website
www.revolka.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • T-Biz Rooms 208, 301, and 309
  • 6-6-40 Aramaki Aoba, Aoba-ku, Miyagi
  • Sendai, Miyagi 980-0845
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Advanced Manufacturing, Big Data, SaaS, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • T-Biz Rooms 208, 301, and 309
  • 6-6-40 Aramaki Aoba, Aoba-ku, Miyagi
  • Sendai, Miyagi 980-0845
  • Japan

RevolKa Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RevolKa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 18-Aug-2025 $5.72M Completed Generating Revenue
4. Accelerator/Incubator 19-Jun-2025 Completed Generating Revenue
3. Early Stage VC 01-Jan-2022 Completed Generating Revenue
2. Seed Round 01-Jun-2021 $9.2K $9.2K Completed Startup
1. Accelerator/Incubator Completed Startup
To view RevolKa’s complete valuation and funding history, request access »

RevolKa Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class A
Class A4
Class A3 15,386 $88.02 $88.02 1x $88.02 29.39%
Class A2 4,524 $74.82 $74.82 1x $74.82 8.64%
To view RevolKa’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

RevolKa Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

RevolKa Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4625420-A1 Antibody design method through machine learning Pending 06-Dec-2022
US-20260204353-A1 Antibody design method through machine learning Pending 06-Dec-2022
WO-2024122449-A1 Antibody design method through machine learning Inactive 06-Dec-2022
EP-4410829-A1 Machine learning-based protein design method Pending 27-Sep-2021
US-20250104809-A1 Machine learning-based protein design method Pending 27-Sep-2021 G16B20/50
To view RevolKa’s complete patent history, request access »

RevolKa Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RevolKa Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
77 Capital Corporate Venture Capital Minority
D3 (Tokyo) Venture Capital Minority
DEEPCORE Venture Capital Minority
SBI Investment Venture Capital Minority
Spurcle Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

RevolKa FAQs

  • When was RevolKa founded?

    RevolKa was founded in 2021.

  • Where is RevolKa headquartered?

    RevolKa is headquartered in Sendai, Japan.

  • What is the size of RevolKa?

    RevolKa has 17 total employees.

  • What industry is RevolKa in?

    RevolKa’s primary industry is Drug Discovery.

  • Is RevolKa a private or public company?

    RevolKa is a Private company.

  • What is the current valuation of RevolKa?

    The current valuation of RevolKa is .

  • What is RevolKa’s current revenue?

    The current revenue for RevolKa is .

  • How much funding has RevolKa raised over time?

    RevolKa has raised $5.73M.

  • Who are RevolKa’s investors?

    77 Capital, D3 (Tokyo), DEEPCORE, SBI Investment, and Spurcle are 5 of 7 investors who have invested in RevolKa.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process